Innovation Pharmaceuticals and U.S. Regional Biocontainment Laboratory Nearing Completion of Brilacidin Anti-SARS-CoV-2 (COVID-19) In Vitro Testing

Ads

You May Also Like

RedHill Biopharma Reports First Quarter 2018 Financial Results

Key Highlights: Top-line results from Phase III study with RHB-104 for Crohn’s disease (MAP ...

Progressive Care Reports Strong November Sales to Begin End of Year Rally

MIAMI, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its subsidiaries ...